Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

一石激起千层浪，引发网友热烈讨论。网友纷纷表示此事难以置信，从没听说过什么药物的保质期长达20年！还有一些朋友问，既然达菲可以保质20年，那么仿制药奥司他韦是否可以类推？

Xofluza (baloxavir marboxil) is already approved to treat people infected with flu, but the new results make a case to extend its use to include healthy people at risk of contracting the virus ...